French National Institute of Health and Medical Research (INSERM)
Jeremie Guedj is a researcher in biostatistics/pharmacometrics at Inserm since 2012. After obtaining his PhD from University of Bordeaux in 2006, he worked as a postdoctoral fellow with Avidan Neumann and Alan Perelson on HCV dynamics in the era of direct acting antivirals. His research has theoretical and clinical objectives, such as understanding drug’s mechanism of action and optimizing their efficacy, in chronic (HIV, HBV) and acute emerging viral infections (SARS-COV-2, Ebola). He also applies the methods developed in virus dynamics to other fields of research, in particular bacterial dynamics (microbiota, phage therapy) or cancer therapy.
Wednesday, November 4, 2020
10:30 AM – 11:00 AM ET